Yahud Ella, Paul Gideon, Rahkovich Michael, Vasilenko Lubov, Kogan Yonatan, Lev Eli, Laish-Farkash Avishag
Cardiology Division, Assuta Ashdod University Hospital, Ha-Refua St 7, Ashdod 7747629, Israel.
Eur Heart J Case Rep. 2020 Dec 12;4(6):1-9. doi: 10.1093/ehjcr/ytaa376. eCollection 2020 Dec.
Cannabis use is known to be associated with significant cardiovascular morbidity. We describe three cases of cannabis-related malignant arrhythmias, who presented to the cardiac department at our institution within the last 2 years. All three patients were known to smoke cannabis on daily basis.
Case 1: A 30-year-old male, presented with recent onset of palpitations. A 12-lead electrocardiogram (ECG), transthoracic echocardiogram (TTE), and blood tests were all normal. During an inpatient exercise treadmill test (ETT) he developed polymorphic ventricular tachycardia (VT), which converted spontaneously to supraventricular tachycardia (SVT) in the recovery phase of the test. Subsequent risk stratification with cardiac magnetic resonance imaging and coronary angiography showed no abnormalities and an electrophysiological study was negative for sustained VT, however, SVT was easily induced with rapid conversion to atrial fibrillation. The patient successfully stopped smoking all tobacco products including cannabis and was treated with beta-blockers, with no further episodes of arrhythmia. Case 2: A 30-year-old male presented to the Emergency Department with palpitations, chest pain, and dizziness that improved during exertion. His initial ECG demonstrated complete atrioventricular block (AVB). Subsequent traces showed Mobitz Type I and second-degree AVB, which converted to atrial flutter after exertion. Routine blood tests, TTE, and an ETT were all normal and he was discharged home with no conduction abnormalities. Case 3: A 24-year-old male presented with two episodes of syncope. Baseline examination was normal, with an ECG showing a low atrial rhythm. Interrogation of his implantable loop recorder showed episodes of early morning bradycardia episodes with no associated symptoms.
Cannabis-related arrhythmia can be multiform regarding their presentation. Therefore, ambiguous combinations of arrhythmia should raise suspicion of underlying cannabis abuse, where clinically appropriate. Although causality with regards to cannabis use cannot be proven definitively in these cases, the temporal relationship between drug use and the onset of symptoms suggests a strong association.
已知使用大麻与显著的心血管疾病发病率相关。我们描述了三例与大麻相关的恶性心律失常病例,他们在过去两年内到我们机构的心脏科就诊。所有三名患者均已知每天吸食大麻。
病例1:一名30岁男性,近期出现心悸。12导联心电图(ECG)、经胸超声心动图(TTE)和血液检查均正常。在住院运动平板试验(ETT)期间,他出现了多形性室性心动过速(VT),在试验恢复期自发转为室上性心动过速(SVT)。随后通过心脏磁共振成像和冠状动脉造影进行的风险分层显示无异常,电生理研究对持续性VT为阴性,然而,SVT很容易诱发并迅速转为房颤。患者成功戒除了包括大麻在内的所有烟草制品,并接受了β受体阻滞剂治疗,未再出现心律失常发作。病例2:一名30岁男性因心悸、胸痛和头晕到急诊科就诊,这些症状在运动时有所改善。他最初的心电图显示完全性房室传导阻滞(AVB)。随后的心电图显示莫氏I型和二度AVB,运动后转为心房扑动。常规血液检查、TTE和ETT均正常,他出院时无传导异常。病例3:一名24岁男性出现两次晕厥发作。基线检查正常,心电图显示低位心房节律。对其植入式环路记录仪的询问显示有清晨心动过缓发作,无相关症状。
与大麻相关的心律失常在表现形式上可能多种多样。因此,心律失常的不明确组合应在临床上适当的情况下引发对潜在大麻滥用的怀疑。尽管在这些病例中不能明确证明与大麻使用存在因果关系,但药物使用与症状发作之间的时间关系表明存在很强的关联。